Search results for: 'research area pi3k akt signaling s6 kinase'
-
A4122 PHA-680632Target: Aurora Kinases|PLK|FGFRSummary: Aurora kinase inhibitor,novel and potent
-
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A2597 Brivanib (BMS-540215)Target: VEGFR|FGFR|Flk1Summary: VEGFR-2 inhibitor,ATP-competitive
-
A3870 TG 100801Target: VEGFR|FGFR|Src|Fyn kinaseSummary: Multi-kinase inhibitor
-
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).